Nel ASA Lands $12 Million Collins Aerospace Order for Submarine Life-Support Systems
Published on 09/30/2026 at 09:41 | Editorial boerse-global.de
Nel ASA's American subsidiary has secured a firm order from Collins Aerospace worth roughly $12 million, a deal that will see the Norwegian group supply PEM (Proton Exchange Membrane) electrolyser stacks for oxygen generation aboard US submarines. Nel Hydrogen US booked the contract yesterday, with deliveries scheduled to run across 2027 and 2028.
The win gives Nel a foothold in security-critical procurement programmes, where technical reliability is non-negotiable and the commercial backdrop tends to be steadier than in the wider hydrogen industry. It also marks another demonstration of the company's technology in a specialised military application. That said, the order is a far cry from the large-scale industrial hydrogen projects that dominate the sector's growth narrative.
Cash Flow Timing Takes Centre Stage
For investors, the calendar matters as much as the contract value. While the $12 million bolsters the PEM division's order book, it does nothing for near-term liquidity. Because shipments are spread over 2027 and 2028, the immediate cash flow remains untouched, leaving Nel to fund ongoing operating costs from existing resources until then. The order sharpens long-term visibility without resolving the earnings questions hanging over the coming quarters.
On the technology front, the repeat deployment of PEM stacks on US submarines reinforces the platform's credentials with industrial buyers. The stacks themselves will be manufactured at Nel's plant in Wallingford, Connecticut, giving the group a North American industrial base alongside its European sales channels. The company also closed a framework agreement with Hydrasun just over three weeks ago, covering the build-out of assembly and integration capacity for the MC series in Aberdeen.
Should investors sell immediately? Or is it worth buying Nel ASA?
Analysts Stay on the Sidelines
Market watchers remain unconvinced. Their caution rests on structural problems: the global electrolyser market is wrestling with pronounced overcapacity, intensifying both competition and pricing pressure. Nel's worldwide share sits in the low single digits, and the company continues to post balance-sheet losses, complicating any fundamental re-rating.
Strategic uncertainty adds to the drag. More than a month has passed since the CEO succession was left unresolved, clouding day-to-day leadership and depriving the group of clear signals on its future direction. The long delivery window through 2028 ties up resources without generating near-term profit.
Share Price Reflects the Mixed Picture
The conflicting signals are visible in the trading tape. The stock posted a modest gain of 1.4% today to €0.1946, yet a broader recovery remains elusive. Against its 52-week high, the shares are still 47% lower. Yesterday's close came in at €0.1920, below the 200-day moving average of €0.2125 — a gap that underscores how sceptical market participants are about operating margins.
Whether niche contracts of this kind can offset the overcapacity and persistent losses flagged by industry observers is the central question for the share price from here. The immediate technical test lies at the 52-week low of €0.1731: holding that support keeps the prospect of stabilisation alive, while a break below it could open the door to further declines. The next operational signpost is the resolution of the vacant CEO post, ahead of the Collins Aerospace deliveries getting under way in 2027.
Ad
Nel ASA Stock: New Analysis - 30 September
Fresh Nel ASA information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
